Price:$36.95 Free Shipping + Save up to 20%! Learn
more
References
AREDS Report No. 8. A randomized, placebo-controlled clinical trial
of high-dose supplementation with vitamins
C and E,
beta
carotene, and zinc
for age-related macular degeneration and vision loss. Arch Ophthalmol
119: 1417-1436, 2001.
The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group.
The effect of vitamin
E and beta-carotene
on the incidence of lung cancer and other cancers in male smokers.
N Engl J Med 330: 1029-1035, 1994.
Omenn GS, et al. Effects of a combination of beta-carotene
and vitamin
A on lung cancer and cardiovascular disease. N Engl J Med 334:
1150-1155, 1996.
Bruno RS, et al. Alpha tocopherol disappearance is faster in cigarette
smokers and is inversely related to their ascorbic acid status. Am
J Clin Nutr 81: 95-103, 2005.
Kelly G. (Review) The interaction of cigarette smoking and antioxidants
Part III: Ascorbic acid. Alt Med Rev 8: 43-54, 2003.
Moeller SM, et al. The potential role of dietary xanthophylls in
cataract and age-related macular degeneration. J Am Coll Nutr 19:
522S-527S, 2000.
Ferslew KE, Acuff RV, Daigneault EA, Woolley TW and Stanton PE.
Pharmacokinetics and bioavailability of the RRR and all racemic stereoisomers
of alpha-tocopherol in humans after single oral administration. J
Clin Pharmacol 33: 84-88, 1993.
Traber MG, Elsner A and Brigelius-Flohe R. Synthetic as compared
with natural vitamin
E is preferentially excreted as alpha-CEHC in human urine: studies
using deuterated alpha-tocopheryl acetates. FEBS Letters 437: 145-148,
1998.
Weinstein SJ. Serum alpha-tocopherol and gamma-tocopherol in relation
to prostate cancer risk in a prospective study. J Natl Cancer Inst.
97: 396-399, 2005.
Morris MC, et al. Relation of the tocopherol forms to incident Alzheimer
disease and to cognitive change. A J Clinc Nutr 81: 508-514, 2005.14.
Stahl. W. Review: Macular carotenoids: lutein and zeaxanthin.
Dev Ophthalmol 38: 70-88, 2005.
Grahn BH, et al. Review: Zinc
and the eye. J Am Coll Nutr 20: 106-118, 2001.
Landrum JT, et al. Lutein,
zeaxanthin
and the macular pigment. Arch Biochem Biophys 385: 28-40, 2001.
Beatty S, et al. Macular pigment and risk for age-related macular
degeneration in subjects from a Northern European population. Invest
Ophthalmol Vis Sci 42: 439-446, 2001.
Bone RA, et al. Macular pigment in donor eyes with and without AMD:
a case-control study. Invest Ophthalmol Vis Sci 42: 235-240, 2001.
Johnson EJ, et al. Relation among serum and tissue concentrations
of lutein
and zeaxanthin
and macular pigment density. Am J Clin Nutr 71: 1555-1562, 2000.
Berendschot TT, et al. Influence of lutein
supplementation on macular pigment, assessed with two objective techniques.
Invest Ophthalmol Vis Sci 41: 3322-3326, 2000.
Hammond BR, et al. Dietary modification of human macular pigment
density. Invest Ophthalmol Vis Sci 38: 1795-1801, 1997.
Humphries JM, et al. Distribution of lutein,
zeaxanthin,
and related geometrical isomers in fruit, vegetables, wheat, and pasta
products. J Agric Food Chem 51: 1322-1327, 2003.
De la Paz MA, et al. Antioxidant enzymes of the human retina. Curr
Eye Res 15: 273-278, 1996.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Return
to Top